Evidence map›Paper›PMID 30397682›Full record

ArticleJournal of preventive medicine and hygiene2018

The never-ending story of the fight against tuberculosis: from Koch's bacillus to global control programs.

M Martini, G Besozzi, I Barberis

Open access · greenAbstract readHistorical Article
In one paragraph

Article in Journal of preventive medicine and hygiene, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 35 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Establishment of minimum protein standards forMycobacteria (London, England) · 2025
    Article
  6. Article
  7. Review
  8. Article
  9. History of primary health care in Iran.Journal of preventive medicine and hygiene · 2023
    Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Review
  16. Extracellular Vesicles in Mycobacteria and Tuberculosis.Frontiers in cellular and infection microbiology · 2022
    Review
  17. Article
  18. Review
  19. Article
  20. Journal of preventive medicine and hygiene · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

M MartiniUniversity of Genoa, Department of Health Sciences, Section of Medical History and Ethics, Genoa, Italy.
G BesozziCentro di Formazione TB Italia Onlus.
I BarberisUniversity of Genoa, Department of Health Sciences, Section of Medical History and Ethics, Genoa, Italy.
University of Genoa · ITAssociazione Italiana Vulvodinia Onlus · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tuberculosis (TB) is one of the oldest diseases known to affect humanity, and is still a major public health problem. It is caused by the bacillus Mycobacterium tuberculosis (MT), isolated in 1882 by Robert Koch. Until the 1950s, X rays were used as a cheap method of diagnostic screening together with the tuberculin skin sensitivity test. In the diagnosis and treatment of TB, an important role was also played by surgery. The late Nineteenth century saw the introduction of the tuberculosis sanatorium, which proved to be one of the first useful measures against TB. Subsequently, Albert Calmette and Camille Guérin used a non-virulent MT strain to produce a live attenuated vaccine. In the 1980s and 1990s, the incidence of tuberculosis surged as a major opportunistic infection in people with HIV infection and AIDS; for this reason, a combined strategy based on improving drug treatment, diagnostic instruments and prevention was needed.

Indexed as

Communicable Disease ControlGlobal HealthAntitubercular AgentsBacillusDrug DiscoveryDrug Resistance, MultipleHistory, 19th CenturyHistory, 20th CenturyHIV InfectionsHumansMass ScreeningMycobacterium tuberculosisTuberculosisTuberculosis VaccinesAntitubercular AgentsTuberculosis VaccinesBacille Calmette GuerìnHistory of tuberculosisMycobacterium tuberculosisTuberculosis control strategy

Identifiers

PMID30397682
PMCPMC6196368
OpenAlexW2901356771

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.